Clinical Trial

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Recruiting
View on ClinicalTrials.gov →
Summary
1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-05-19; most recent amendment 2023-12-14.
Trial Details
NCT Number NCT05388682
Lead Sponsor Chinese Pulmonary Vascular Disease Research Group
Conditions Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, PAH Targeted Medication
Enrollment 200 participants
Start Date 2014-01-19
Primary Completion 2042-12-31 (estimated)
Study Completion 2042-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-12-20